Mutational inactivation of the tumour suppressor gene p53 (a regulator of cell growth and death) is frequently found in human tumours, with p53 mutation/inactivation reported in 63–65% of high-grade gliomas [27]. Here, TP53 is linked to central nervous system cancer.